SINTX Technologies Inc. (NASDAQ: SINT) stock gained by 4.84% at last close while the SINT stock price rises by 2.31% in the pre-market trading session. SINTX Technologies is a customized ceramics manufacturer that creates and sells sophisticated ceramics for medical and non-medical purposes.
SINT stock’ Current Update
The National Institute of Health (NIH) has granted SINTX Technologies $308,301 Phase 1 funding to build a 3-D printed composite silicon nitride – polyetheretherketone (SN-PEEK) spinal implant. This research funding from the National Institutes of Health (NIH) focuses on the antibacterial and osseointegrative characteristics of silicon nitride and is SINTX’s first NIH grant.
PEEK-based spinal implants are preferred because of its long-standing security and utility profile, accounting for about 40% of the $10 billion worldwide spine industry. SINTX hopes to capitalise on the advantages of PEEK while also incorporating the antibacterial and osteoconductive properties of silicon nitride through the creation of 3D printed SN-PEEK implants. This will be accomplished through the use of contemporary, cost-effective 3D printing techniques.
In the next 9-11 months, SINTX will work with Drexel University, Thomas Jefferson University, and the University Of Pennsylvania School Of Veterinary Medicine to create a 3D printed SN-PEEK composite spinal implant that fulfils the American Society for Testing and Materials’ static loading demands, as well as characterise its antibacterial activity and impact on osteoblast proliferation and maturation. The National Institutes of Health’s Department of Health and Human Sciences funded the research presented in the “3D Printed Silicon Nitride Porous PEEK Composite Spinal Cages for Anti-Infection” proposal with award number R41GM146268-01.
Dr. Sonny Bal, President, and CEO, SINTX Technologies stated,
Dr. Steven Kurtz, Dr. Noreen Hickok, and Dr. Thomas Schaer all contributed significantly to the proposal, and they appreciate their continuing support. The NIH funding is a significant step toward incorporating silicon nitride’s antibacterial and osseointegrative characteristics into SN-PEEK composite structures. This NIH-funded study is an essential step in their aim to develop a new generation of unique spinal implants for potential partners from a commercial viewpoint.
